This inventor holds 1 USPTO granted patent. Top assignees: Kyoto University, Takeda Pharmaceutical Company Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 871 
1 out of 1,228 
Years Active: 2026
Title: Yuta Mishima: Innovator in Hematopoietic Research
Introduction
Yuta Mishima is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of hematopoietic research, particularly through his innovative patent.
Latest Patents
Mishima holds a patent for a hematopoietic progenitor cell marker. This patent provides a method for producing a CD4/CD8 double positive cell, which is crucial for advancing research in immunology and cell therapy. He has 1 patent to his name.
Career Highlights
Throughout his career, Yuta Mishima has worked with prestigious institutions, including Kyoto University and Takeda Pharmaceutical Company Limited. His work in these organizations has allowed him to develop and refine his research in hematopoietic cells.
Collaborations
Mishima has collaborated with esteemed colleagues such as Shin Kaneko and Shoichi Iriguchi. These partnerships have further enhanced his research and contributions to the scientific community.
Conclusion
Yuta Mishima's innovative work in hematopoietic research exemplifies the impact of dedicated inventors in advancing medical science. His contributions continue to influence the field and inspire future research endeavors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile